Jacynthe Comtois

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Diminishing returns of disease-modifying treatment in older participants of multiple sclerosis clinical trials.

Diminishing returns of disease-modifying treatment in older participants of multiple sclerosis clinical trials.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 20, 2026

Breaking the PROMISE: poor association between brain volume loss and clinical disability worsening over 2 years of follow-up in primary progressive multiple sclerosis.

Breaking the PROMISE: poor association between brain volume loss and clinical disability worsening over 2 years of follow-up in primary progressive multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 04, 2025

Extended window of relapse recovery in RRMS: an analysis of the DECIDE dataset.

Extended window of relapse recovery in RRMS: an analysis of the DECIDE dataset.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: May 13, 2025

Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study.

Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 08, 2025

Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis.

Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis.

Journal: Neurology

Published: February 17, 2025

Measuring cognitive change in secondary progressive MS: an analysis of the ASCEND cognition substudy.

Measuring cognitive change in secondary progressive MS: an analysis of the ASCEND cognition substudy.

Journal: Journal of neurology

Published: January 27, 2025

Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS.

Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: September 09, 2024

Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults.

Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: February 05, 2024

Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx dataset.

Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx dataset.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: October 13, 2023

Threshold definitions for significant change on the timed 25-foot walk and nine-hole peg test in primary progressive multiple sclerosis.

Threshold definitions for significant change on the timed 25-foot walk and nine-hole peg test in primary progressive multiple sclerosis.

Journal: European journal of neurology

Published: February 14, 2023

Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis.

Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: December 09, 2022

The nine hole peg test as an outcome measure in progressive MS trials.

The nine hole peg test as an outcome measure in progressive MS trials.

Journal: Multiple sclerosis and related disorders

Published: July 30, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026